MT2022-36 A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects withSevere Sickle Cell Disease;C Genotype

Project: Research project


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.


Immunology and Microbiology